Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes

Journal of Neuroimmunology

Volumn 142, Issue 1-2, 2003, Pages 58-66

  Badea, Tudor D ^a   Park, Jae Hyun ^a   Soane, Lucian ^a   Niculescu, Teodora ^a   Niculescu, Florin ^a   Rus, Horea ^a   Shin, Moon L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

C fos; ERK1; Myotube; Serum response factor; Terminal complement complex C5b 9

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; SERUM RESPONSE FACTOR; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR ELK 1; DNA; DNA BINDING PROTEIN; ELK1 PROTEIN, HUMAN; ELK1 PROTEIN, MOUSE; LYMPHOID ENHANCER FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR;

ADULT; ANIMAL CELL; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOASSAY; MOUSE; MYOTUBE; NONHUMAN; ONCOGENE C FOS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DNA RESPONSIVE ELEMENT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; ONCOGENE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSACTIVATION;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELL LINE; COMPLEMENT MEMBRANE ATTACK COMPLEX; DNA; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION REGULATION; GENES, FOS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SKELETAL; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; RESPONSE ELEMENTS; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0642309618     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00261-3     Document Type: Article

References (45)

1. Biesecker G., Gomez C.M. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. J. Immunol. 142:1989;2654-2659.
2. Brown J.R., Nigh E., Lee R.J., Ye H., Thompson M.A., Saudou F., Pestell R.G., Greenberg M.E. Fos family members induce cell cycle entry by activating cyclin D1. Mol. Cell. Biol. 18:1998;5609-5619.
3. Carney D.F., Hammer C.H., Shin M.L. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+. J. Immunol. 137:1986;263-270.
4. Carney D.F., Lang T.J., Shin M.L. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J. Immunol. 145:1990;623-629.
5. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
6. Chen C.Y., Gherzi R., Ong S.E., Chan E.L., Raijmakers R., Pruijn G.J., Stoecklin G., Moroni C., Mann M., Karin M. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell. 107:2001;451-464.
7. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
8. Cybulsky A.V., Bonventre J.V., Quigg R.J., Lieberthal W., Salant D.J. Cytosolic calcium and protein kinase C reduce complement-mediated glomerular epithelial injury. Kidney Int. 38:1990;803-811.
9. Gasque P., Dean Y.D., McGreal E.P., VanBeek J., Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology. 49:2000;171-186.
10. Gineitis D., Treisman R. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 276:2001;24531-24539.
11. Graham R., Gilman M. Distinct protein targets for signals acting at the c-fos serum response element. Science. 251:1991;189-192.
12. Grosset C., Chen C.Y., Xu N., Sonenberg N., Jacquemin-Sablon H., Shyu A.B. A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell. 103:2000;29-40.
13. Halperin J.A., Taratuska A., Nicholson-Weller A. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J. Clin. Invest. 91:1993;1974-1978.
14. Hughes S.M. Muscle development: reversal of the differentiated state. Curr. Biol. 11:2001;R237-R239.
15. Lang T.J., Badea T.C., Wade R., Shin M.L. Sublytic terminal complement attack on myotubes decreases the expression of mRNAs encoding muscle-specific proteins. J. Neurochem. 68:1997;1581-1589.
16. Lennon V.A., Seybold M.E., Lindstrom J.M., Cochrane C., Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J. Exp. Med. 147:1978;973-983.
17. Ling Y., West A.G., Roberts E.C., Lakey J.H., Sharrocks A.D. Interaction of transcription factors with serum response factor. Identification of the Elk-1 binding surface. J. Biol. Chem. 273:1998;10506-10514.
18. Mendell J.R., Garcha T.S., Kissel J.T. The immunopathogenic role of complement in human muscle disease. Curr. Opin. Neurol. 9:1996;226-234.
19. Morgan B.P., Dankert J.R., Esser A.F. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J. Immunol. 138:1987;246-253.
20. Niculescu F., Rus H., Shin S., Lang T., Shin M.L. Generation of diacylglycerol and ceramide during homologous complement activation. J. Immunol. 150:1993;214-224.
21. Niculescu F., Rus H., Shin M.L. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J. Biol. Chem. 269:1994;4417-4423.
22. Niculescu F., Rus H., van Biesen T., Shin M.L. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. J. Immunol. 158:1997;4405-4412.
23. Niculescu F., Badea T., Rus H. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis. 142:1999;47-56.
24. Niculescu F., Soane L., Badea T., Shin M., Rus H. Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells. Immunopharmacology. 42:1999;187-193.
25. Niculescu F., Hila S., Fosbrink M., Soane L., Popescu T., Shustova V., Rus V., Shin M.L., Rus H. Endothelial cell proliferation induced by sublytic C5b-9 requires the activation of p70S6 kinase through a mechanism involving the G-protein dependent activation of phosphatidylinositol 3-kinase. Int. Immunopharmacol. 318:2002;1219A.
26. Nissen L.J., Gelly J.C., Hipskind R.A. Induction-independent recruitment of CREB-binding protein to the c-fos serum response element through interactions between the bromodomain and Elk-1. J. Biol. Chem. 276:2001;5213-5221.
27. Odelberg S.J., Kollhoff A., Keating M.T. Dedifferentiation of mammalian myotubes induced by msx1. Cell. 103:2000;1099-1109.
28. Rommel C., Clarke B.A., Zimmermann S., Nunez L., Rossman R., Reid K., Moelling K., Yancopoulos G.D., Glass D.J. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science. 286:1999;1738-1741.
29. Rus H.G., Niculescu F., Shin M.L. Sublytic complement attack induces cell cycle in oligodendrocytes. J. Immunol. 156:1996;4892-4900.
30. Rus H.G., Niculescu F.I., Shin M.L. Role of the C5b-9 complement complex in cell cycle and apoptosis. Immunol. Rev. 180:2001;49-55.
31. Scibek J.J., Plumb M.E., Sodetz J.M. Binding of human complement C8 to cC9: role of the N-terminal modules in the c8alpha subunit. Biochemistry. 41:2002;14546-14551.
32. Seeger W., Suttorp N., Hellwig A., Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J. Immunol. 137:1986;1286-1293.
33. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:2002;E131-E136.
34. Shaw P.E. Ternary complex formation over the c-fos serum response element: p62TCF exhibits dual component specificity with contacts to DNA and an extended structure in the DNA-binding domain of p67SRF. EMBO J. 11:1992;3011-3019.
35. Shin M.L., Rus H.G., Niculescu F.I. Membranes attack by complement: assembly and biology of the terminal complement complexes. AG L. Biomembranes. vol. 4:1996;123-149 JAI Press, Greenwhich, CT.
36. Shin M.L., Rus H., Niculescu F. Complement system in central nervous system disorders. Volanakis J.E., Frank M.M. The Human Complement System in Health and Disease. 1998;499-525 Marcel Dekker, New York.
37. Shirazi Y., McMorris F.A., Shin M.L. Arachidonic acid mobilization and phosphoinositide turnover by the terminal complement complex, C5b-9, in rat oligodendrocyte×C6 glioma cell hybrids. J. Immunol. 142:1989;4385-4391.
38. Shirazi Y., Rus H.G., Macklin W.B., Shin M.L. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J. Immunol. 150:1993;4581-4590.
39. Shyu A.B., Greenberg M.E., Belasco J.G. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:1989;60-72.
40. Strahl T., Gille H., Shaw P.E. Selective response of ternary complex factor Sap1a to different mitogen-activated protein kinase subgroups. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11563-11568.
41. Treisman R. Journey to the surface of the cell: fos regulation and the SRE. EMBO J. 14:1995;4905-4913.
42. Treisman R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:1996;205-215.
43. Woloshin P., Song K., Degnin C., Killary A.M., Goldhamer D.J., Sassoon D., Thayer M.J. MSX1 inhibits myoD expression in fibroblast×10T1/2 cell hybrids. Cell. 82:1995;611-620.
44. Yamada H., Kudoh I., Nishizawa H., Kaneko K., Miyazaki H., Ohara M., Okumura F. Complement partially mediates acid aspiration-induced remote organ injury in the rat. Acta Anaesthesiol. Scand. 41:1997;713-718.
45. Zinck R., Hipskind R.A., Pingoud V., Nordheim A. c-fos transcriptional activation and repression correlate temporally with the phosphorylation status of TCF. EMBO J. 12:1993;2377-2387.